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ABSTRACT 
The aim of the proposed research work was to develop a unique dual-compartment capsule dosage form of ciprofloxacin 
hydrochloride (CHL) which is well-known to have short elimination half-life and narrow absorption window. Formulated dual-
compartment capsules were evaluated for its suitability for stomach specific drug delivery by employing different polymers such as 
Guar gum, Xanthan gum. Formulations were assessed for interaction studies, in vitro buoyancy, effect of polymer concentration on 
drug release and release kinetics. Experimental results demonstrated that natural polymers can be effectively exercised to formulate 
capsule dosage form for improved gastro retention and sustained drug release; which may be better and economic alternative for 
synthetic polymers. 
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INTRODUCTION: 
The real challenge in the development of an oral 
controlled-release drug delivery system is not just to 
sustain the drug release but also to prolong the presence 
of the dosage form within the gastrointestinal tract 
(GIT) until all the drug is completely released at the 
desired period of time
1
. Floating systems are of two 
types: (A) effervescent systems, depending on the 
generation of carbon dioxide gas upon contact with 
gastric fluids and (B) non-effervescent systems. Ring 
Cap, a patented technology could be an example of such 
development. The intent of such technology was to 
provide a delivery system with reliable and reproducible 
drug release characteristics
2
. CHL is a broad‐spectrum 
antibiotic that is active against both gram‐positive and 
gram‐negative bacteria. It functions by inhibiting DNA 
gyrase, a type II topoisomerase, which is an enzyme 
necessary to separate replicated DNA, thereby inhibiting 
cell division. It is rapidly absorbed orally and shows 
60‐70% oral bioavailability and 3‐ 4 hours elimination 
half‐life3. The use of naturally occurring biocompatible 
polymeric materials has been the focus of recent 
research activity in the design of dosage forms for oral 
controlled release administration. Gums from natural 
sources hydrate and swell on contact with water and 
these have been used for the preparation of single unit 
dosage forms. Xanthan gum offers potential utility as a 
drug carrier because of its inertness and 
biocompatibility. It is used as an effective excipients for 
sustained release formulations.  Guar gum is used in 
solid dosage forms as a binder, disintegrant, and as a 
polymer in the floating drug delivery system. Karaya 
gum is a partially acetylated polymer of galactose, 
rhamnose, and glucuronic acid. The intention of 
purposed investigation was to develop a floating ring 
cap delivery system in cross-linked hard gelatin capsule 
shell by employing natural polymers and to assess their 
effectiveness as a better and economic alternative for 
synthetic polymers in form of floating ring capsule for 
enhanced gastroretention and sustained drug release
4
. 
MATERIALS AND METHODS 
Ciprofloxacin hydrochloride was supplied as a generous 
gift sample from Ajanta Pharmaceuticals Ltd. (Jalgaon, 
India). Xanthan gum and Eudragit
®
 S 100 was 
purchased from Research Lab, Fine Chemicals Ltd. 
(Mumbai, India). Guar gum and Karaya gum, HPMC 
K15M was purchased from Loba Chem. Pvt. Ltd., 
(Mumbai, India). All other chemicals and reagents used 
were of analytical grade. 
Preparation of separating ring cap band: 
Separating ring cap band was prepared by film casting 
method; the method employed 2% HPMC solution in 
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water, followed by the addition of 5% glycerol. Formed 
mixture was poured into petri dish and was allowed to 
dry at 45 °C. The dried film was cut uniformly into 
circular rings with punch, each having 1 mm thickness 
and 5.1 mm in diameter
4
 
Preparation of enteric gelatin body 
Enteric gelatin bodies were prepared by dipping method. 
Hard gelatin body portion of capsule was separated from 
the cap and dipped in coating solution. Coating solution 
was made by dissolving the Eudragit S 100 in acetone. 
Coated capsule were air-dried overnight for complete 
removal of organic solvent. 
Preparation of new floating ring capsules: 
Enteric coated gelatin body of capsule was filled with 50 
mg powder Xanthan gum at bottom and separating ring 
band placed over it manually, then physically blended 
250 mg of CHL with natural polymers like guar gum, 
xanthan gum and karaya gum (Table I) in different 
weight proportion were filled into hard gelatin capsule 
(# 0.), Finally enteric coated capsule body was sealed 
with hard gelatin cap Figure.1 
 
 
Figure 1: An image showing assembly of floating ring capsule 
 
Table I: Formulations of floating capsules 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Formulation  
code 
Drug (mg) Guar gum 
(mg) 
Xanthan gum 
(mg) 
Karaya gum 
(mg) 
F1 250 5 - - 
F2 250 10 - - 
F3 250 20 - - 
F4 250 30 - - 
F5 250 40 - - 
F6 250 50 - - 
F7 250 80 - - 
F8 250 - 10 - 
F9 250 - 20 - 
F10 250 - 30 - 
F11 250 - 40 - 
F12 250 - 50 - 
F13 250 - 80 - 
F14 250 - - 20 
F15 250 - - 30 
F16 250 - - 40 
F17 250 - - 50 
F18 250 - - 60 
F19 250 - - 70 
F20 250 - - 80 
F21 250 - - 90 
F22 250 - - 100 
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Evaluation of dual-compartment capsules 
formulations 
Weight uniformity: 20 capsules were weighed 
individually and the average weight was determined. 
Test was performed according to the official method. 
Drug content:   The Ciprofloxacin ring capsules of each 
formulation were dissolved in 0.1 N HCl, then prepared 
solution was used for determination of Ciprofloxacin 
hydrochloride content by using a UV- 
spectrophotometer. 
In vitro buoyancy study: In vitro buoyancy was studied 
by determining floating time of capsules in 0.1 N HCl. 
The duration of buoyancy was determined in 0.1 N SGF 
(Simulated gastric fluid) as a medium by using the USP 
type II dissolution apparatus at 50 rpm and temperature 
was maintained at 37±5°C. The floating duration of all 
capsules was measured by visual observation (USP). 
In vitro drug release studies: In vitro drug release study 
was carried in USP (paddle) dissolution apparatus at 50 
rpm and temperature maintained at 37 ± 1°C. 
RESULTS AND DISCUSSION: 
Weight uniformity: The results of weight uniformity of 
formulation F1, F12 and F22 are shown in Table 2. All 
these developed formulations met the I.P specifications 
for weight uniformity. 
Drug content: The percent drug content within these 
developed capsules was determined and this was within 
the range between 98.18 ± 1.02 to 98.94 ± 1.29 % (Table 
III). This finding confirms uniform mixing of CHL with 
other formulation ingredients. 
 
Table 2: Weight uniformity and percent drug content results of ciprofloxacin hydrochloride capsules 
Formulation Code Weight Uniformity Drug Content(%) ± S.D* 
Mean weight ± S.D.* (mg) 
F1 308.34 ± 2.54 98.18 ± 1.02 
F12 349.73 ± 7.47 99.68 ± 1.00 
F22 401.14 ± 6.88 98.94 ± 1.29 
   
In vitro buoyancy study: The air entrapped in dense 
powder during filling operation of capsules aids for the 
buoyancy phenomena. They were floated well without 
floating lag time. The floating time of these floating ring 
capsules was more than 8 hours. This may be accounted 
due to increased gel strength of the polymeric 
combination matrices with drug. 
In vitro drug release studies:  
 
Figure 2: Comparison of in vitro release between 
formulations F1, F12, and F22. 
The drug release from floating capsules was found to be 
15.64 to 30.95 % for F1 to F7 with Guar gum. The drug 
release from formulations F8 to F13 varied between 
27.55 to 81.08% for Xanthan gum and F14 to F22 varied 
between 26.93 to 93.53% for Karaya gum. It was 
observed that the type of natural gum influences the drug 
release pattern. Varying the amount of guar gum, 
xanthan gum, and karaya gum affect the drug release. 
Formulations F1, F12 and F22 showed prolonged drug 
release for more than 8 hours emerging as best 
formulations. 
CONCLUSION 
In the present study ciprofloxacin hydrochloride floating 
ring capsule using natural gums like guar gum, xanthan 
gum and karaya gum were developed. The type of 
polymer affects the drug release rate and the mechanism. 
Formulation F12 showed sustained drug release for 8 
hours so it was selected as the best formulation among 
all the formulation. The Kinetics of drug release was 
best explained by first order equation. The results of 
current study clearly indicate a promising potential of 
these floating ring capsules containing ciprofloxacin 
hydrochloride as an improved alternative to for 
gastroretentive sustained release dosage forms.
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